Your browser doesn't support javascript.
loading
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer.
Lehto, Timo-Pekka K; Kovanen, Ruusu-Maaria; Lintula, Susanna; Malén, Adrian; Stürenberg, Carolin; Erickson, Andrew; Pulkka, Olli-Pekka; Stenman, Ulf-Håkan; Diamandis, Eleftherios P; Rannikko, Antti; Mirtti, Tuomas; Koistinen, Hannu.
Afiliação
  • Lehto TK; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Kovanen RM; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lintula S; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Malén A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Stürenberg C; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Erickson A; Department of Clinical Chemistry and Haematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Pulkka OP; Department of Clinical Chemistry and Haematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Stenman UH; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Diamandis EP; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Rannikko A; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Mirtti T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Koistinen H; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
Int J Cancer ; 153(4): 867-881, 2023 08 15.
Article em En | MEDLINE | ID: mdl-37139608

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptor PAR-1 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptor PAR-1 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia